RCSB PDB - PNX Ligand Summary Page

Chemical Component Summary
Name	3,7-DIMETHYL-1-(5-OXOHEXYL)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE
Identifiers	3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione
Formula	C₁₃ H₁₈ N₄ O₃
Molecular Weight	278.31
Type	NON-POLYMER
Isomeric SMILES	Cn1cnc2N(C)C(=O)N(CCCCC(C)=O)C(=O)c12
InChI	InChI=1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3
InChIKey	BYPFEZZEUUWMEJ-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	38
Chiral Atom Count	0
Bond Count	39
Aromatic Bond Count	10

Drug Info: DrugBank

DrugBank ID	DB00806
Name	Pentoxifylline
Groups	approved investigational
Description	A methylxanthine derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production. [PubChem]
Synonyms	Pentoxifyllin Oxpentifylline Pentoxifilina Pentoxifylline Pentoxifyllinum
Brand Names	Pentoxifylline 0.5% / Triamcinolone Acetonide 0.1% Trental Tab 400mg Ratio-pentoxifylline Gapeam Budibac Nu-pentoxifylline-SR 400 mg Trental Srt 400mg Pentoxifylline SR Betamethasone Dipropionate 0.05% / Minoxidil 5% / Niacinamide 2% / Pentoxifylline 0.5% Trental Pentoxifylline Pentoxil
Indication	For the treatment of patients with intermittent lameness or immobility arising from chronic occlusive arterial disease of the limbs.
Categories	Alkaloids Antioxidants Antiplatelet agents Blood Viscosity Reducer Cardiovascular Agents Compounds used in a research, industrial, or household setting Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 Substrates Drugs for Obstructive Airway Diseases Drugs that are Mainly Renally Excreted Enzyme Inhibitors Free Radical Scavengers Hematologic Activity Alteration Hematologic Agents Hemorrheologic Agents Heterocyclic Compounds, Fused-Ring Peripheral Vasodilators Phosphodiesterase 5 Inhibitors Phosphodiesterase Inhibitors Protective Agents Purine Derivatives Purines Purinones Radiation-Protective Agents Vasodilating Agents Xanthine derivatives
ATC-Code	C04AD03 R03DA20
CAS number	6493-05-6

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Adenosine receptor A1	MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVS...	unknown	antagonist
Adenosine receptor A2a	MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAA...	unknown	antagonist
5'-nucleotidase	MCPRAARAPATLLLALGAVLWPAAGAWELTILHTNDVHSRLEQTSEDSSK...	unknown	inhibitor
Phosphodiesterase enzymes	-	unknown	inhibitor
Cytochrome P450 1A2	MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Prepare Data

Validate Data

Deposit Data

Deposition Help & Resources

167327 Biological Macromolecular Structures Enabling Breakthroughs in Research and Education

PNX

3,7-DIMETHYL-1-(5-OXOHEXYL)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE

Chemical Component Summary

Chemical Details

Drug Info: DrugBank

Drug Targets